Health Care & Life Sciences » Pharmaceuticals | Concordia International Corp.

Concordia International Corp.

Concordia International Corp.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD5495.62
Market Cap
CAD2.34 B
Shares Outstanding
51.28 M
Public Float
43.94 M

Profile

Address
277 Lakeshore Road East
Oakville Ontario L6H 1J9
Canada
Employees -
Website http://www.concordiarx.com
Updated 09/14/2018
Concordia International Corp. is a pharmaceutical company, which engages in owning and licensing a diversified portfolio of branded and generic prescription products. It operates through the Concordia North America and Concordia International segments. The Concordia North America segment focuses primarily on the United States pharmaceutical market and offers products under the brand of Donnatal, Zonegran, Nilandron, Lanoxin, Plaquenil, and Photofrin.

Financials

View All
Created with Highcharts 5.0.14Concordia International Corp.Net Income. Fiscal year is January-December. All values CAD Millions.33131338381 7411 7412 0652 0652013201420152016201705001000150020002500
Created with Highcharts 5.0.14Concordia International Corp.Sales/Revenue. Fiscal year is January-December. All values CAD Millions.42421351355045041 0811 08181381320132014201520162017025050075010001250

Itzhak Krinsky
Chairman
Robert J. Manzo
Director